• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Aluminum transfer as glutamate complex through blood-brain barrier. Possible implication in dialysis encephalopathy.

作者信息

Deloncle R, Guillard O, Clanet F, Courtois P, Piriou A

机构信息

Laboratoire de Chimie Bio-inorganique, Faculté de Pharmacie, Tours, France.

出版信息

Biol Trace Elem Res. 1990 Apr;25(1):39-45. doi: 10.1007/BF02990262.

DOI:10.1007/BF02990262
PMID:1696110
Abstract

In vitro distribution of aluminium between plasma and erythrocytes has been studied in the presence of variable amounts of sodium L-glutamate. With a red blood cell suspension in isotonic sodium chloride, aluminium remains confined in erythrocytes even when the sodium L-glutamate concentration increases in the medium. Aluminium initially present in plasma penetrates red blood cells when sodium L-glutamate increases in whole blood, showing that this metal is able in vitro to cross the erythrocyte membrane as glutamate complex. In vivo experiments with male Wistar rats prove that aluminium is also able to pass the blood--brain barrier as glutamate complex and deposit in the brain cortex.

摘要

相似文献

1
Aluminum transfer as glutamate complex through blood-brain barrier. Possible implication in dialysis encephalopathy.
Biol Trace Elem Res. 1990 Apr;25(1):39-45. doi: 10.1007/BF02990262.
2
Aluminium studies in dialysis encephalopathy.透析性脑病中的铝研究。
Proc Eur Dial Transplant Assoc. 1978;15:157-63.
3
Modification of the blood-brain barrier through chronic intoxication by aluminum glutamate. Possible role in the etiology of Alzheimer's disease.通过谷氨酸铝慢性中毒对血脑屏障的改变。在阿尔茨海默病病因学中的可能作用。
Biol Trace Elem Res. 1995 Jan-Mar;47(1-3):227-33. doi: 10.1007/BF02790121.
4
[Progressive dialytic encephalopathy. Role of the aluminium and neurological study. One case (author's transl)].
Nouv Presse Med. 1979 Mar 17;8(13):1071-4.
5
[Progressive myoclonic encephalopathy in dialysis patients: presence of high concentrations of aluminium in the lysosomes of the cerebral cells (author's transl)].
Nouv Presse Med. 1979 Dec 24;8(50):4091-4.
6
[Progressive myoclonic encephalopathy in dialysis patients. The role of the water used for haemodialysis (author's transl)].
Nouv Presse Med. 1978 Jan 14;7(2):97-102.
7
Aluminium toxicity during regular haemodialysis.常规血液透析期间的铝中毒
Br Med J. 1978 Apr 29;1(6120):1101-3. doi: 10.1136/bmj.1.6120.1101.
8
Distribution of aluminium between plasma and erythrocytes.血浆与红细胞之间铝的分布
Hum Toxicol. 1985 Nov;4(6):643-8. doi: 10.1177/096032718500400613.
9
[Reversible dialytic encephalopathy after interruption of aluminium intake. 6 cases (author's transl)].
Nouv Presse Med. 1979 Sep 10;8(34):2729-33.
10
Aluminum intoxication in dialysis patients.
Int J Artif Organs. 1982 Sep;5(5):293-6.

引用本文的文献

1
Modification of the blood-brain barrier through chronic intoxication by aluminum glutamate. Possible role in the etiology of Alzheimer's disease.通过谷氨酸铝慢性中毒对血脑屏障的改变。在阿尔茨海默病病因学中的可能作用。
Biol Trace Elem Res. 1995 Jan-Mar;47(1-3):227-33. doi: 10.1007/BF02790121.
2
Mechanism of Alzheimer's disease: arguments for a neurotransmitter-aluminium complex implication.阿尔茨海默病的发病机制:关于神经递质 - 铝复合物关联的论据
Neurochem Res. 1990 Dec;15(12):1239-45. doi: 10.1007/BF01208586.

本文引用的文献

1
Ocular toxicity of high-dose intravenous desferrioxamine.大剂量静脉注射去铁胺的眼部毒性
Lancet. 1983 Jul 23;2(8343):181-4. doi: 10.1016/s0140-6736(83)90170-8.
2
Treatment of dialysis osteomalacia with desferrioxamine.
Lancet. 1982 Aug 14;2(8294):343-5. doi: 10.1016/s0140-6736(82)90544-x.
3
Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.去铁胺治疗后铝透析脑病的逆转
Lancet. 1981 Nov 14;2(8255):1116. doi: 10.1016/s0140-6736(81)91324-6.
4
Successful removal of aluminium from patient with dialysis encephalopathy.成功从患有透析性脑病的患者体内清除铝。
Lancet. 1980 Sep 27;2(8196):692-3. doi: 10.1016/s0140-6736(80)92728-2.
5
Thrombocytopenia associated with intravenous desferrioxamine.与静脉注射去铁胺相关的血小板减少症。
Am J Kidney Dis. 1985 Oct;6(4):254-6. doi: 10.1016/s0272-6386(85)80183-9.
6
Absorption and disposition of aluminum in the rat.大鼠体内铝的吸收与分布
J Pharm Sci. 1986 Jun;75(6):586-9. doi: 10.1002/jps.2600750613.
7
[Severe ocular toxicity of desferrioxamine in the hemodialyzed patient].[去铁胺在血液透析患者中的严重眼部毒性]
Nephrologie. 1987;8(1):27-9.
8
Mucormycosis--a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload?毛霉菌病——透析患者铝或铁过载时去铁胺治疗的新风险?
N Engl J Med. 1987 Jul 2;317(1):54. doi: 10.1056/NEJM198707023170114.
9
Aluminum and Alzheimer's disease.铝与阿尔茨海默病
Neurobiol Aging. 1986 Nov-Dec;7(6):525-32. doi: 10.1016/0197-4580(86)90102-8.
10
Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions.接受皮下去铁胺输注患者的视觉和听觉神经毒性。
N Engl J Med. 1986 Apr 3;314(14):869-73. doi: 10.1056/NEJM198604033141402.